|Bid||94.33 x 800|
|Ask||94.99 x 800|
|Day's Range||93.86 - 94.42|
|52 Week Range||48.02 - 95.43|
|Beta (5Y Monthly)||1.23|
|PE Ratio (TTM)||6.30|
|Earnings Date||May 10, 2021 - May 14, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||94.00|
Magellan Health (MGLN) partners Trapelo Health to offer an all-inclusive approach to value-based care in the innovative arena of precision oncology treatments.
Magellan Rx Management and Trapelo Health are collaborating to offer a precision oncology platform for next-generation care.
Amalgamated Employee Benefits Administrators, one of the nation's leading third party administrators (TPA) for unions, businesses, associations and self-insured plans, announced today that it has launched AEBRx (www.aebrx.com), a new Pharmacy Benefit Administration (PBA) service. This union affiliated, innovative, end-to-end PBA service will focus on helping plan sponsors effectively manage high-cost specialty drugs while providing excellent service and access to a national network of retail pharmacies with mail order capabilities. Amalgamated Employee Benefits Administrators has partnered with Magellan Rx Management, a full-service pharmacy benefits management division of Magellan Health, Inc. (NASDAQ: MGLN) as the engine for AEBRx.